Antibiotic resistance: an editorial review with recommendations
- PMID: 21720654
Antibiotic resistance: an editorial review with recommendations
Abstract
Within a relatively short period of time after the first antimicrobial drugs were introduced, bacteria began exhibiting varying degrees of resistance. The excessive use (and abuse) of antibiotics in agriculture, and in both human and veterinary medicine, has played a critical causative role in the development of antibiotic resistance, which is now recognized as a global public health threat. Increasing concern over this issue should impact the practice of cutaneous medicine and surgery, as dermatologists can easily adopt new healthcare delivery patterns that might reduce the development of antibiotic resistance and still achieve acceptable treatment outcomes. Dermatologists should seriously consider any and all alternative therapies before committing to an extended course of antibiotic therapy for disease entities that are almost certainly not infectious. Conversely, dermatologists should carefully and closely adhere to dosage and duration recommendations when using antibiotics to treat a bona fide infectious disorder.
Similar articles
-
Reducing antimicrobial resistance through appropriate antibiotic usage in Singapore.Singapore Med J. 2008 Oct;49(10):749-55. Singapore Med J. 2008. PMID: 18946605
-
The beginning of the end of the antibiotic era? Part I. The problem: abuse of the "miracle drugs".Quintessence Int. 1998 Mar;29(3):151-62. Quintessence Int. 1998. PMID: 9643250 Review.
-
Antimicrobial resistance.Bull World Health Organ. 1983;61(3):383-94. Bull World Health Organ. 1983. PMID: 6603914 Free PMC article.
-
[Optimizing antibiotics use policy in the Netherlands. I. The Netherlands Antibiotics Policy Foundation (SWAB)].Ned Tijdschr Geneeskd. 1998 Apr 25;142(17):949-51. Ned Tijdschr Geneeskd. 1998. PMID: 9623167 Dutch.
-
Status report on antibiotic resistance: implications for the dermatologist.Dermatol Clin. 2007 Apr;25(2):127-32, v. doi: 10.1016/j.det.2007.01.001. Dermatol Clin. 2007. PMID: 17430749 Review.
Cited by
-
An Antibacterial Peptide with High Resistance to Trypsin Obtained by Substituting d-Amino Acids for Trypsin Cleavage Sites.Antibiotics (Basel). 2021 Nov 28;10(12):1465. doi: 10.3390/antibiotics10121465. Antibiotics (Basel). 2021. PMID: 34943677 Free PMC article.
-
Meeting the Challenges of Acne Treatment in Asian Patients: A Review of the Role of Dermocosmetics as Adjunctive Therapy.J Cutan Aesthet Surg. 2016 Apr-Jun;9(2):85-92. doi: 10.4103/0974-2077.184043. J Cutan Aesthet Surg. 2016. PMID: 27398008 Free PMC article. Review.
-
Inhibition of ribosomal subunit synthesis in Escherichia coli by the vanadyl ribonucleoside complex.Curr Microbiol. 2013 Aug;67(2):226-33. doi: 10.1007/s00284-013-0350-5. Epub 2013 Mar 20. Curr Microbiol. 2013. PMID: 23512123 Free PMC article.
-
The vanadyl ribonucleoside complex inhibits ribosomal subunit formation in Staphylococcus aureus.J Antimicrob Chemother. 2012 Sep;67(9):2152-7. doi: 10.1093/jac/dks182. Epub 2012 May 29. J Antimicrob Chemother. 2012. PMID: 22643191 Free PMC article.
-
Impairment of ribosomal subunit synthesis in aminoglycoside-treated ribonuclease mutants of Escherichia coli.Arch Microbiol. 2012 Dec;194(12):1033-41. doi: 10.1007/s00203-012-0839-5. Epub 2012 Aug 29. Arch Microbiol. 2012. PMID: 22930249 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical